Literature DB >> 19491264

Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte.

Si Brask Sonne1, Kristian Almstrup, Marlene Dalgaard, Agnieszka Sierakowska Juncker, Daniel Edsgard, Ludmila Ruban, Neil J Harrison, Christian Schwager, Amir Abdollahi, Peter E Huber, Søren Brunak, Lise Mette Gjerdrum, Harry D Moore, Peter W Andrews, Niels E Skakkebaek, Ewa Rajpert-De Meyts, Henrik Leffers.   

Abstract

Testicular germ cell cancers in young adult men derive from a precursor lesion called carcinoma in situ (CIS) of the testis. CIS cells were suggested to arise from primordial germ cells or gonocytes. However, direct studies on purified samples of CIS cells are lacking. To overcome this problem, we performed laser microdissection of CIS cells. Highly enriched cell populations were obtained and subjected to gene expression analysis. The expression profile of CIS cells was compared with microdissected gonocytes, oogonia, and cultured embryonic stem cells with and without genomic aberrations. Three samples of each tissue type were used for the analyses. Unique expression patterns for these developmentally very related cell types revealed that CIS cells were very similar to gonocytes because only five genes distinguished these two cell types. We did not find indications that CIS was derived from a meiotic cell, and the similarity to embryonic stem cells was modest compared with gonocytes. Thus, we provide new evidence that the molecular phenotype of CIS cells is similar to that of gonocytes. Our data are in line with the idea that CIS cells may be gonocytes that survived in the postnatal testis. We speculate that disturbed development of somatic cells in the fetal testis may play a role in allowing undifferentiated cells to survive in the postnatal testes. The further development of CIS into invasive germ cell tumors may depend on signals from their postpubertal niche of somatic cells, including hormones and growth factors from Leydig and Sertoli cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491264      PMCID: PMC2869030          DOI: 10.1158/0008-5472.CAN-08-4554

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Expression of protamine-1 and -2 mRNA during human spermiogenesis.

Authors:  K Steger; K Pauls; T Klonisch; F E Franke; M Bergmann
Journal:  Mol Hum Reprod       Date:  2000-03       Impact factor: 4.025

3.  Genome profiles of familial/bilateral and sporadic testicular germ cell tumors.

Authors:  Sigrid Marie Kraggerud; Rolf I Skotheim; Jadwiga Szymanska; Mette Eknaes; Sophie D Fosså; Anna E Stenwig; Päivi Peltomäki; Ragnhild A Lothe
Journal:  Genes Chromosomes Cancer       Date:  2002-06       Impact factor: 5.006

4.  TM4: a free, open-source system for microarray data management and analysis.

Authors:  A I Saeed; V Sharov; J White; J Li; W Liang; N Bhagabati; J Braisted; M Klapa; T Currier; M Thiagarajan; A Sturn; M Snuffin; A Rezantsev; D Popov; A Ryltsov; E Kostukovich; I Borisovsky; Z Liu; A Vinsavich; V Trush; J Quackenbush
Journal:  Biotechniques       Date:  2003-02       Impact factor: 1.993

Review 5.  Carcinoma in situ in the testis.

Authors:  M Rørth; E Rajpert-De Meyts; L Andersson; K P Dieckmann; S D Fosså; K M Grigor; W F Hendry; H W Herr; L H Looijenga; J W Oosterhuis; N E Skakkebaek
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

6.  Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas.

Authors:  C Rosenberg; R J Van Gurp; E Geelen; J W Oosterhuis; L H Looijenga
Journal:  Oncogene       Date:  2000-11-30       Impact factor: 9.867

Review 7.  Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects.

Authors:  N E Skakkebaek; E Rajpert-De Meyts; K M Main
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

8.  A receptor-type protein tyrosine phosphatase PTP zeta is expressed in human cutaneous melanomas.

Authors:  T Goldmann; F Otto; E Vollmer
Journal:  Folia Histochem Cytobiol       Date:  2000       Impact factor: 1.698

9.  POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

Authors:  Leendert H J Looijenga; Hans Stoop; Hubert P J C de Leeuw; Carlos A de Gouveia Brazao; Ad J M Gillis; Kees E P van Roozendaal; Everardus J J van Zoelen; Rob F A Weber; Katja P Wolffenbuttel; Herman van Dekken; Friedemann Honecker; Carsten Bokemeyer; Elizabeth J Perlman; Dominik T Schneider; Juha Kononen; Guido Sauter; J Wolter Oosterhuis
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

10.  Optimizing staining protocols for laser microdissection of specific cell types from the testis including carcinoma in situ.

Authors:  Si Brask Sonne; Marlene D Dalgaard; John Erik Nielsen; Christina E Hoei-Hansen; Ewa Rajpert-De Meyts; Lise Mette Gjerdrum; Henrik Leffers
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240

View more
  56 in total

1.  Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.

Authors:  Russ Hauser; Niels E Skakkebaek; Ulla Hass; Jorma Toppari; Anders Juul; Anna Maria Andersson; Andreas Kortenkamp; Jerrold J Heindel; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

Review 2.  The role of vitamin D in male fertility: A focus on the testis.

Authors:  Cristina de Angelis; Mariano Galdiero; Claudia Pivonello; Francesco Garifalos; Davide Menafra; Federica Cariati; Ciro Salzano; Giacomo Galdiero; Mariangela Piscopo; Alfonso Vece; Annamaria Colao; Rosario Pivonello
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

Review 3.  Germ cell tumors: Insights from the Drosophila ovary and the mouse testis.

Authors:  Helen K Salz; Emily P Dawson; Jason D Heaney
Journal:  Mol Reprod Dev       Date:  2017-03       Impact factor: 2.609

Review 4.  Vitamin D and male reproduction.

Authors:  Martin Blomberg Jensen
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

5.  Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.

Authors:  Martin Blomberg Jensen; Anne Jørgensen; John Erik Nielsen; Andreas Steinmeyer; Henrik Leffers; Anders Juul; Ewa Rajpert-De Meyts
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

Review 6.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

7.  Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control.

Authors:  Juliette Gimenez; Cécile Montgiraud; Jean-Philippe Pichon; Bertrand Bonnaud; Maud Arsac; Karine Ruel; Olivier Bouton; François Mallet
Journal:  Nucleic Acids Res       Date:  2010-01-06       Impact factor: 16.971

8.  Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors.

Authors:  Cassy M Spiller; Ad J M Gillis; Guillaume Burnet; Hans Stoop; Peter Koopman; Josephine Bowles; Leendert H J Looijenga
Journal:  Mol Oncol       Date:  2015-11-18       Impact factor: 6.603

9.  Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Authors:  Michael C Risk; Timothy A Masterson
Journal:  Indian J Urol       Date:  2010 Jan-Mar

10.  Laser capture microdissection of gonads from juvenile zebrafish.

Authors:  Anne Jørgensen; John E Nielsen; Jane E Morthorst; Poul Bjerregaard; Henrik Leffers
Journal:  Reprod Biol Endocrinol       Date:  2009-09-14       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.